Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by kingposton Jan 04, 2015 11:56pm
124 Views
Post# 23284977

RE:RE:RE:RE:Iscfa which is it to be

RE:RE:RE:RE:Iscfa which is it to be
lscfa wrote: Nonsense. Those costs (e.g. FDA approved plants) of TEVA and Mylan are also borne by Vanc's manufacturers and get passed through in the prices the manufacturers charge Vanc.



cojtract manufacturers are way more efficient than teva and mylan at doing what they focus on manufacturing ... better economies of scale, plant utilization etc...  The bigger pharmas are wasteful and because they do not subcontract out they plants are not even utilized fully, many problems over seeing over seas manufacting also...out of sight out of mind...
Bullboard Posts